Health

Companies engaged in biotechnology, pharmaceuticals, research services, home healthcare, hospital operations, long‑term care, and the manufacture and supply of medical equipment and supplies. The sector also includes pharmaceutical retailers and providers of health‑information services. UK‑listed companies in this sector include AstraZeneca plc, GlaxoSmithKline plc, Smith & Nephew plc, Hikma Pharmaceuticals plc, ConvaTec Group plc, Spire Healthcare plc and EMIS Group plc.

GSK receives EU approval for Nucala in Eosinophilic COPD

GSK plc announced that the European Commission has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults with uncontrolled COPD characterised by raised blood eosinophils...

February 6, 2026

Brava Health CMO urges human-centred approach to MedTech

Brava Health’s CMO calls on the MedTech industry to align innovation with clinical responsibility at a key industry event...

February 5, 2026

Verici Dx delivers FY25 growth as Tutivia™ commercialisation accelerates

For the year ended 31 December 2025, Verici Dx Plc reported unaudited revenues of $3.8m, driven by first recognised Tutivia™ revenues, increased test volumes, and expanded US reimbursement coverage...

February 5, 2026

Verici Dx secures BCBS Illinois agreement for Tutivia kidney transplant test

Verici Dx Plc has entered into an agreement with Blue Cross and Blue Shield of Illinois to provide in-network coverage for Tutivia™, its post-kidney transplant diagnostic test...

February 5, 2026

Oxford Biomedica expands strategic partnership with Bristol Myers Squibb

Oxford Biomedica has signed a new Commercial Supply Agreement with Bristol Myers Squibb for the manufacture and supply of lentiviral vectors for CAR-T programmes...

February 4, 2026

GSK reports strong 2025 results and reaffirms long-term growth outlook

GSK delivered a strong financial performance in 2025, with sales of £32.7 billion driven by double-digit growth in Specialty Medicines across Respiratory, Immunology & Inflammation, Oncology and HIV...

February 4, 2026

Cizzle Biotechnology secures Canadian patent for CIZ1B lung cancer test

Cizzle Biotechnology has been granted Canadian patent protection for methods measuring the CIZ1B lung cancer biomarker, strengthening its intellectual property portfolio...

February 4, 2026

AstraZeneca Plc begins trading on the New York Stock Exchange

AstraZeneca has started trading its ordinary shares on the NYSE for the first time, aligning its listings across New York, London and Stockholm under a harmonised structure...

February 2, 2026

Delay damages patients, and the system pays for it

In joint surgery, delays don’t just postpone care, they increase risk, reduce recovery and raise long-term cost...

January 30, 2026

AstraZeneca signs $1.2bn obesity drug collaboration with CSPC

Under a new agreement with CSPC Pharmaceuticals, AstraZeneca will advance eight programmes targeting obesity and weight-related conditions, initially progressing four assets through Phase I...

January 30, 2026

Aptamer Group secures £270k in new orders and first cash licensing receipts

Aptamer Group plc has announced £190,000 in new fee-for-service Optimer® orders and £80,000 in cash licensing receipts, including its first payment from a hot-start PCR licence...

January 29, 2026

Positioning physician practices for long-term financial control

Earl Anderson shares how physician practices are adapting strategy and ownership to stay financially viable in a changing healthcare market...

January 27, 2026

Tutivia™ study confirms predictive value in transplant care

AI-powered kidney transplant test flags risk of rejection before symptoms appear, study shows...

January 27, 2026

Brava Health builds infrastructure for individual-led healthcare

Brava Health is making health data user-owned and ready for the future of care...

January 27, 2026

EU approves GSK’s Arexvy RSV vaccine for adults 18+

GSK plc announced that the European Commission has approved its RSV vaccine, Arexvy, for use in adults aged 18 years and older...

January 26, 2026

Ethtry Plc publishes new Company Presentation

Ethtry has published a new Company presentation outlining its strategy, business model, and growth outlook across key markets, including tokenised assets and sovereign blockchain infrastructure...

January 23, 2026

Who owns healthcare now?

Invest in the platforms, that’s where healthcare value lives now...

January 21, 2026

Ethtry Plc sets out refreshed operating strategy

Ethtry PLC has adopted a refreshed operating strategy, confirming its strategic focus on breakthrough technologies including quantum technologies, artificial intelligence, data centres, energy transition and Web3, alongside its ongoing Ethereum Treasury Policy...

January 21, 2026

Brava Health partners with AMV to add movement intelligence to Health OS

Brava Health announced a strategic partnership with Academy Medtech Ventures to embed AI-powered movement intelligence into Brava Health OS...

January 20, 2026

Ethtry Plc purchases 500 Ethereum as part of treasury strategy

Ethtry has acquired 500 Ethereum at an average price of £2,412 per ETH, investing £1.205 million as part of the ongoing implementation of its Ethereum Treasury Policy...

January 20, 2026

News and Interview Alerts

Company Presentations

Cerillion Plc Annual KPIs. Substantial Pipeline. Stronger Competitive Position

RECI presentation: High-yielding, controlled-risk lending supports near 10% dividend yield

Q&As

ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager

6 February 2026

BlueNord ASA fund manager expects very substantial cash generation for years

6 February 2026

Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed

4 February 2026

Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager

4 February 2026

Hardman & Co

NB Private Equity Partners 2025 CMD: good returns from low-risk PE model

10 December 2025

Real Estate Credit Investments (RECI): Investor Day: opportunities aplenty

2 December 2025

Volta Finance: Liquid access to outperforming private credit

6 October 2025

Real Estate Credit Investments: What RECI brings to investors

15 September 2025

Chesnara Plc: Showing good operational progress

8 September 2025

Green News

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

23 January 2026

Drax expands FlexGen platform with Flexitricity acquisition

21 January 2026

View all Sustainable sectors, Plcs and news >>

Search

Latest Interviews

The Diverse Income Trust: Why Gervais Williams Is Doubling Down on Overlooked UK Small Caps (video)

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

BrokerTalk

Sintana Energy Strengthens Position with ExxonMobil Settlement, Eyes Growth in 2026 – Auctus Advisors LLP

4 February 2026

Naked Wines Broker Tips Over 120% Price Upside on Profitable Growth – Panmure Liberum

2 February 2026

Alkemy Capital Gains Momentum with Major 5 Year Glencore Deal and Project Financing – Zeus

28 January 2026

Funds

ACG Metals positioned for strong cash generation and long-term value as copper production ramps up, highlights DIVI fund manager

6 February 2026

BlueNord ASA fund manager expects very substantial cash generation for years

6 February 2026

Primary Health Properties surplus cash fuels generous dividend, Gervais Williams impressed

4 February 2026

Arbuthnot Banking Group ‘remarkably low valuation given its prospects’ says DIVI Fund Manager

4 February 2026

View all Funds, Market Insights and news >>

FTSE 100 News

UK Broker Ratings

Workspace Group PLC (WKP.L) Investor Outlook: What the 14.29% Potential Upside Means for You

6 February 2026

Zigup Plc (ZIG.L) Stock Analysis: Industrial Rental Services Giant with a 30% Upside Potential

6 February 2026

WH Smith PLC (SMWH.L) Investor Outlook: Navigating Potential Upside Amidst Market Challenges

6 February 2026

XPS Pensions Group PLC (XPS.L): Analyst Consensus Points to 29% Upside Potential for UK-Based Pension Specialist

6 February 2026

WORLDWIDE HEALTHCARE TRUST PLC (WWH.L) Stock Analysis: A Look at Recent Price Movements Amidst Strong Buy Ratings

6 February 2026

UK Broker Ratings

GSK receives EU approval for Nucala in Eosinophilic COPD

GSK plc announced that the European Commission has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults with uncontrolled COPD characterised by raised blood eosinophils...

February 6, 2026

Brava Health CMO urges human-centred approach to MedTech

Brava Health’s CMO calls on the MedTech industry to align innovation with clinical responsibility at a key industry event...

February 5, 2026

Verici Dx delivers FY25 growth as Tutivia™ commercialisation accelerates

February 5, 2026

Verici Dx secures BCBS Illinois agreement for Tutivia kidney transplant test

Verici Dx Plc has entered into an agreement with Blue Cross and Blue Shield of Illinois to provide in-network coverage for Tutivia™, its post-kidney transplant diagnostic test...

February 5, 2026

Oxford Biomedica expands strategic partnership with Bristol Myers Squibb

Oxford Biomedica has signed a new Commercial Supply Agreement with Bristol Myers Squibb for the manufacture and supply of lentiviral vectors for CAR-T programmes...

February 4, 2026

GSK reports strong 2025 results and reaffirms long-term growth outlook

February 4, 2026

Cizzle Biotechnology secures Canadian patent for CIZ1B lung cancer test

Cizzle Biotechnology has been granted Canadian patent protection for methods measuring the CIZ1B lung cancer biomarker, strengthening its intellectual property portfolio...

February 4, 2026

AstraZeneca Plc begins trading on the New York Stock Exchange

AstraZeneca has started trading its ordinary shares on the NYSE for the first time, aligning its listings across New York, London and Stockholm under a harmonised structure...

February 2, 2026

Delay damages patients, and the system pays for it

In joint surgery, delays don’t just postpone care, they increase risk, reduce recovery and raise long-term cost...

January 30, 2026

AstraZeneca signs $1.2bn obesity drug collaboration with CSPC

Under a new agreement with CSPC Pharmaceuticals, AstraZeneca will advance eight programmes targeting obesity and weight-related conditions, initially progressing four assets through Phase I...

January 30, 2026

Aptamer Group secures £270k in new orders and first cash licensing receipts

Aptamer Group plc has announced £190,000 in new fee-for-service Optimer® orders and £80,000 in cash licensing receipts, including its first payment from a hot-start PCR licence...

January 29, 2026

Positioning physician practices for long-term financial control

Earl Anderson shares how physician practices are adapting strategy and ownership to stay financially viable in a changing healthcare market...

January 27, 2026

Tutivia™ study confirms predictive value in transplant care

AI-powered kidney transplant test flags risk of rejection before symptoms appear, study shows...

January 27, 2026

Brava Health builds infrastructure for individual-led healthcare

Brava Health is making health data user-owned and ready for the future of care...

January 27, 2026

EU approves GSK’s Arexvy RSV vaccine for adults 18+

GSK plc announced that the European Commission has approved its RSV vaccine, Arexvy, for use in adults aged 18 years and older...

January 26, 2026

Ethtry Plc publishes new Company Presentation

Ethtry has published a new Company presentation outlining its strategy, business model, and growth outlook across key markets, including tokenised assets and sovereign blockchain infrastructure...

January 23, 2026

Who owns healthcare now?

Invest in the platforms, that’s where healthcare value lives now...

January 21, 2026

Ethtry Plc sets out refreshed operating strategy

January 21, 2026

Brava Health partners with AMV to add movement intelligence to Health OS

Brava Health announced a strategic partnership with Academy Medtech Ventures to embed AI-powered movement intelligence into Brava Health OS...

January 20, 2026

Ethtry Plc purchases 500 Ethereum as part of treasury strategy

Ethtry has acquired 500 Ethereum at an average price of £2,412 per ETH, investing £1.205 million as part of the ongoing implementation of its Ethereum Treasury Policy...